Einat Brill Almon
2016
In 2016, Einat Brill Almon earned a total compensation of $410.2K as Senior Vice President, Product Development at Protalix BioTherapeutics, a 33% decrease compared to previous year.
Compensation breakdown
| Option Awards | $93,890 |
|---|---|
| Salary | $233,486 |
| Stock Awards | $16,043 |
| Other | $66,822 |
| Total | $410,241 |
Almon received $233.5K in salary, accounting for 57% of the total pay in 2016.
Almon also received $93.9K in option awards, $16K in stock awards and $66.8K in other compensation.
Rankings
In 2016, Einat Brill Almon's compensation ranked 11,832nd out of 14,075 executives tracked by ExecPay. In other words, Almon earned more than 15.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,832 out of 14,075 | 16th |
Division Manufacturing | 4,631 out of 5,489 | 16th |
Major group Chemicals And Allied Products | 1,657 out of 1,895 | 13th |
Industry group Drugs | 1,343 out of 1,538 | 13th |
Industry Biological Products, Except Diagnostic Substances | 241 out of 279 | 14th |
Source: SEC filing on March 16, 2017.
Almon's colleagues
We found four more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2016.
2016
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2016
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2016
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2016
Tzvi Palash
Protalix BioTherapeutics